Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
100.5174369
Mar.Cap(Rs.Cr)
40,225.46
P/E
42.50
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Balance Sheet
ParticularsMar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
SOURCES OF FUNDS :      
Share Capital 169.41169.41169.41169.41169.41169.41
Reserves Total 1779.821614.691583.592508.211327.711670.63
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds1949.231784.101753.002677.621497.121840.04
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 9.9518.6715.5420.0834.630.18
Total Debt9.9518.6715.5420.0834.630.18
Other Liabilities248.40246.30254.22263.00260.29289.39
Total Liabilities2207.582049.072022.762960.701792.042129.61
APPLICATION OF FUNDS :      
Gross Block 668.95683.12635.93593.89602.891454.59
Less : Accumulated Depreciation 385.31361.86305.99263.26216.00696.53
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 283.64321.26329.94330.63386.89758.06
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress14.3213.9320.3130.5013.21120.12
Producing Properties0.000.000.000.000.000.00
Investments 1142.74837.72542.78390.0924.4924.49
Current Assets, Loans & Advances      
Inventories 463.17514.30437.70512.71523.34483.03
Sundry Debtors 292.55222.06192.38205.24215.6099.80
Cash and Bank Balance1400.891061.201150.732479.111157.681066.41
Loans and Advances 108.70155.08167.62108.05274.71107.54
Total Current Assets2265.301952.621948.433305.122171.331756.78
Less : Current Liabilities and Provisions      
Current Liabilities 952.43806.64590.941046.53866.70559.87
Provisions 940.93692.10713.99615.36438.35442.04
Total Current Liabilities & Provisions1893.351498.741304.941661.901305.051001.92
Net Current Assets371.95453.88643.491643.22866.28754.86
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets167.94163.08151.38131.67117.24126.09
Deferred Tax Liability27.3017.1418.2018.8915.5717.24
Net Deferred Tax140.64145.94133.18112.78101.67108.85
Other Assets254.30276.33353.06453.48399.49363.22
Total Assets2207.582049.052022.762960.701792.032129.60
Contingent Liabilities462.03384.15350.59351.10485.78471.42
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)